Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
VCYT
#1439
Veracyte, Inc.
36.590
0
-1.25%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.25%
Changement Mensuel
-8.13%
Evolution sur 6 mois
-0.84%
Changement Annuel
-0.84%
Clôture Précédente
37.055
0
Open
36.590
0
Bid
Ask
Low
36.590
0
High
36.590
0
Volume
138
Marchés
Actions des Marchés US
Soins de Santé
VCYT
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
67 M
71.22 M
72.15 M
75.07 M
77.94 M
79.46 M
—
Valuation ratios
Enterprise value
2.93 B
2.76 B
1.48 B
1.84 B
2.85 B
2.98 B
9.42 B
Price to earnings ratio
—
-37.12
-44.41
-26.86
127.74
51.34
285.55
Price to sales ratio
—
12.74
5.47
5.51
6.94
—
—
Price to cash flow ratio
—
88.46
215.07
45.01
41.22
24.89
105.07
Price to book ratio
—
2.55
1.51
1.91
2.63
2.59
4.09
Enterprise value to EBITDA ratio
35.51
22.68
6.68
—
8.65
—
—
Profitability ratios
Return on assets %
-0.08
-0.06
-0.03
-0.07
0.02
0.05
0.05
Return on equity %
-0.08
-0.07
-0.03
-0.07
0.02
0.05
0.05
Return on invested capital %
-146.85
-57.44
-17.32
-37.56
6.71
23.08
16.96
Gross margin %
99.07
100
100
100
66.88
70.1
280.15
Operating margin %
-30.12
-37.31
-13.85
-23.76
3.62
11.17
30.49
EBITDA margin %
70.23
55.47
74.68
—
73.83
74.14
288.01
Net margin %
-29.71
-34.42
-12.33
-20.61
5.41
12.83
46.29
Liquidity ratios
Quick ratio
22.11
3.61
3.74
4.4
4.46
7.81
23.63
Current ratio
22.39
3.79
3.97
4.66
4.73
8.15
24.9
Inventory turnover
0.19
0
0
—
0.61
0.5
0.47
Asset turnover
0.32
0.27
0.25
0.32
0.37
0.38
0.38
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.47
0.11
0.61
0.96
1.69
1.7
EBIT per share
—
1.5
2.73
—
3.91
4.49
4.39
EBITDA per share
—
1.79
3.1
—
4.21
4.76
4.66
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
2.55
2.5
2.98
3.7
4.5
13.52
Net current asset value per share
—
3.58
3.48
3.93
4.76
6.06
21.66
Tangible book value per share
—
2.74
2.86
3.48
4.19
5.63
19.27
Working capital per share
—
2.64
2.6
3.09
3.76
5.32
18.11
Book value per share
—
16.15
15.03
14.37
15.05
16.25
62.19
Nouvelles
GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery
GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow
Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises
Needham relève l’objectif de cours de Veracyte à 48$ sur fond de croissance
Veracyte stock price target raised to $48 by Needham on growth
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
Veracyte T4 2025 : croissance du chiffre d’affaires de 19%, rentabilité en forte hausse
Veracyte Q4 2025 slides: 19% revenue growth, profitability soars
Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation
BD Launches Urine Complete Cup Kit for Smarter Testing & Accuracy